PubMed HealthSearch

Biomedical subjects

D D Adams

Publications and source records attributed to D D Adams.

11 recordsLinked to original sources

Three theories which explain the occurrence and inheritance of the autoimmune diseases.

The immunity system uses random processes. In B lymphocytes these are antigen-driven somatic gene mutations which tighten antibody affinity for invading microbes to enable recovery from and prevention of infectious diseases. In T lymphocytes, randomized gene segment combinations continually provide new clones, needed to counter continually-changing microbial parasites. Because these B and T cell processes are random, they entail risk of producing forbidden (self-antigen-reactive) clones, a minority of which cause autoimmune diseases, as envisaged by Burnet in his forbidden clone theory. A corollary of the forbidden clone theory is the V gene theory, postulating that the specificities of the germline variable (V) genes coding for antigen receptors influence the risks of autoimmune diseases. The H gene theory, postulates that the main defense against autoimmune disease is mediated by the permanent, unbreakable tolerances imposed on the clonal repertoire by the histocompatibility (H) antigens, major, minor and H-Y. Recent work shows that the last two act as peptides which modify MHC antigens by occupying their Bjorkman grooves. The absolute absence of autoimmunity to histocompatibility, ABO and H-Y antigens shows that nascent clones with high affinity for these white cell antigens are continually eliminated. Application of molecular biological techniques has shown that H antigen tolerance impositions profoundly alter the clonal repertoire and hence the risks of development of the forbidden clones which cause the autoimmune diseases. Precise basic theory is crucially important for effective application of molecular biology and microbiology to the eminently achievable therapeutic and prophylactic conquest of the ubiquitous autoimmune diseases.

Animals

A computer interface for psychophysical and speech research with the Nucleus cochlear implant.

A computer interface has been designed and implemented that allows presentation of biphasic pulse stimuli to patients with the Nucleus Ltd./Cochlear Corporation cochlear implant. The one version of the interface connects to a standard parallel output port of a PC or AT compatible computer, and another version plugs directly into a standard PC/XT bus slot. The host computer sends a stream of bytes to the parallel port that specifies the configuration of the desired output pulses. Upon receipt of the data, the interface generates the appropriate burst sequence that is delivered to the patient's external transmitter coil. The coded information is interpreted by the internal receiver that delivers the pulse to the specified electrodes at the specified amplitude and pulse width. This interface makes it possible to interleave pulses on two or more electrode pairs, to modulate the amplitude or timing of a pulse sequence, or to sweep a stimulus across the electrode array. Investigators can achieve stimulus control with this interface that allows them to conduct psychophysical, electrophysiological, and speech experiments not possible through the patient's speech processor or with available clinical interfaces.

Cochlear Implants

Three genes for lupus nephritis in NZB x NZW mice.

The occurrence of early severe lupus nephritis in (NZB x NZW)F1 mice must depend on the action of at least two dominant or codominant genes (at least one gene from each parent) as neither of the inbred parental strains shows the disorder. Identifying affected animals by antemortem determinations of renal function, we have studied the incidence of the renal disease in 230 (NZB x NZW) x NZW backcross mice (an earlier study) and, in this study, in 150 (NZB x NZW) x NZB backcross mice. The data indicate that the NZB strain contributes only one gene and the NZW strain contributes two genes, or clusters of closely linked genes, to the renal disorder of the F1 hybrid. One of the NZW genes was found to be linked to the H-2 complex. All three genes must be dominant or codominant, as their effect is expressed in the heterozygous state.

Animals

The genetic contribution of the NZB mouse to the renal disease of the NZB x NZW hybrid.

The occurrence of lupus nephritis in (NZB x NZW)F1 mice appears to depend on the action of at least two dominant or co-dominant genes (at least one gene from each parent) as neither of the inbred parental strains shows the disorder. Identifying affected animals by antemortem determinations of renal function, using improved methods of measuring proteinuria and renal clearance, we have studied the incidence of the renal disease in 230 (NZB x NZW)F1 x NZW backcross mice. The incidence was 49-6% which indicates that NZB strain contributes only one gene, or cluster of closely linked genes, to the renal disorder of the F1 hybrid. The gene(s) must be dominant or co-dominant, as it expresses its effect in the heterozygous state. Study of the H-2 status of the backcross mice showed a loose linkage of the NZB renal disease gene(s) to the D end of the H-2 complex, the crossover frequency being 32-6+/-3-1%.

Aging

Evidence that mouse thyroid stimulator does not stimulate the human thyroid gland.

Thyroid 131I uptake and human thyroid stimulator (HTS) level were measured in 20 untreated thyrotoxic patients who also showed mouse thyroid stimulator (MTS) ACtivity. The correlation between thyroid uptake and HTS level was highly significant (P less than 0-005), the coefficient, r, being 0-66, comparable with the value 0-68 obtained in a previous study of patients not showing MTS. Thus, the presence of widely varying amounts of MTS does not impair the close correlation existing between HTS level and thyroid 131I uptake in thyrotoxic people. There was no correlation between MTS level and thyroid 131I uptake (r = 0-11, n.s.). It is concluded that MTS, a potent stimulator of the thyroid glands of mice, guinea pigs and monkeys, does not stimulate the human thyroid gland.

Animals

Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin.

Serum thyroid-stimulating autoantibodies (LATS and LATS protector) and thyrotropin (TSH) concentrations were measured in the serum of 30 patients with hyperthyroidism living in Tasmania who developed their disease following correction of iodine deficiency by addition of iodate to the bread. Patients were grouped according to thyroid scan results. None of 8 patients with autonomous thyroid nodules had thyroid-stimulating autoantibodies. These were present in both of the patients with uniform thyroid scans and 14 of 20 patients (70%) with irregular scans without demonstrated localized autonomy. Serum TSH, measured by immunoassay of concentrated serum extracts, was 0.15 muU/ml or less in all patients, below the range of 0.35 to 2.60 muU/ml found in normal subjects. Only 6 (20%) of the 30 patients failed to show either localized autonomy or thyroid-stimulating autoantibodies. In most regards these patients resembled those with antonomous nodules. The findings support the conclusion that the increased incidence of phyerthyroidism in Tasmania was due to an increased supply of iodine to patients with latent hyperthyroidism whose thyroid glands, due to the presence of toxid nodule(s) or thyroid-stimulating autoantibodies, were unresponsive to control by TSH deprivation. There was no evidence for additional pathogenic mechanisms

Adult